Corporate Banner
Satellite Banner
Scientific Communities
Become a Member | Sign in
Home>News>This Article

Huber Presents the 4 Aces of Temperature Control!

Published: Thursday, August 15, 2013
Last Updated: Thursday, August 15, 2013
Bookmark and Share
Huber has a winning hand with a suite of very compact, high efficiency and low-cost products.

Huber offers temperature control systems to match the demands of almost any application requirement. Ranging from the Unistat Hybrid, which can be integrated into centralised systems for large volume reactors, to small chillers, immersion and circulation thermostats. Despite their size, these units are real all-rounders, offering incredible power with small foot prints and environmentally friendly refrigeration – making them truly product aces.

The Petite Fleur with a working temperature of -40 °C to +200 °C is the smallest, hydraulically sealed dynamic temperature control system in the Unistat series and ideally suited to control small research reactors.

Since its launch, the Petite Fleur has become a bestseller in the Huber product range. The Petite Fleur has unique thermodynamic properties and in comparison to other machines, the Petite Fleur is unrivaled when it comes to responsive temperature control.

Huber Ministats are the smallest cooling thermostats in the world! Despite their size they have enough power to thermoregulate photometers, refractometers, viscosimeters, distillation apparatus, reactor vessels and mini plants. Their compact form allows them to be placed in areas where space is at a premium, for example laboratory extraction hoods. Ministats are available in 3 models with a temperature range from -45 °C to +200 °C and cooling capacities of 600 watts. They can be used to control externally closed applications or alternatively objects can be thermoregulated directly within the bath.

The compact Minichiller is designed as a space saving tower and with a footprint of just 225 x 360 mm it takes up less bench space than many laptops. With a temperature range of -20 °C to +40 °C and cooling capacity of 300 watts at 15 °C, Minichillers are ideal for cooling reaction blocks, vapour traps, vacuum pump condensers, rotary evaporators or heat exchangers, supplying predictable and correct pressure, flow and temperature to applications resulting in tangible process efficiencies. It ensures constant temperatures and highly efficient condensation of flow through vapours. The Minichiller is designed for continuous operation in ambient temperatures up to +40 °C.

The Compatible Control models and the simpler MPC circulators are modern classics. Both product lines represent classically constructed laboratory circulators with open baths. The pump, control sensor, heater and evaporator are all located at the back part of the bath. This allows the use of both, optional calibration inserts for high precision calibration and also displacement inserts for increasing system temperature dynamics. Baths and circulators for heating applications up to +300 °C are available, as well as models for heating and cooling applications from -90 °C to +200 °C.

Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,800+ scientific posters on ePosters
  • More Than 4,000+ scientific videos on LabTube
  • 35 community eNewsletters

Sign In

Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Huber to Open US Branch
The new US affiliate will be responsible for sales and service for USA, Canada and Mexico.
Tuesday, December 09, 2014
Scientific News
High Throughput Mass Spectrometry-Based Screening Assay Trends
Dr John Comley provides an insight into HT MS-based screening with a focus on future user requirements and preferences.
Promising Drug Combination for Advanced Prostate Cancer
A new drug combination may be effective in treating men with metastatic prostate cancer. Preliminary results of this new approach are encouraging and have led to an ongoing international study being conducted in 196 hospitals worldwide.
A Cellular Symphony Responsible for Autoimmune Disease
Broad Institute researchers have used a novel approach to increase our understanding of the immune system as a whole.
When it Comes to Breast Cancer, Common Pigeon is No Bird Brain
If pigeons went to medical school and specialized in pathology or radiology, they’d be pretty good at distinguishing digitized microscope slides and mammograms of normal vs. cancerous breast tissue, a new study has found.
Editing of LIMS Data Made Faster and More Efficient in Matrix Gemini
The latest version of the Matrix Gemini LIMS (Laboratory Information Management System) from Autoscribe Informatics now provides faster and more efficient editing of LIMS data by eliminating the need for a second editing screen.
University of Edinburgh, Selcia Achieve Key Milestones in Drug Development Program
Scientists from the University of Edinburgh, working with Selcia, have successfully passed the 20-month milestone targets of a 30-month Wellcome Trust SDDi £2.5 million project to design novel treatments for sleeping sickness.
Red Clover Genome to Help Restore Sustainable Farming
The Genome Analysis Centre (TGAC) in collaboration with IBERS, has sequenced and assembled the DNA of red clover to help breeders improve the beneficial traits of this important forage crop.
How a Genetic Locus Protects Adult Blood-Forming Stem Cells
Mammalian imprinted Gtl2 protects adult hematopoietic stem cells by restricting metabolic activity in the cells' mitochondria.
Genetic Basis of Fatal Flu Side Effect Discovered
A group of people with fatal H1N1 flu died after their viral infections triggered a deadly hyperinflammatory disorder in susceptible individuals with gene mutations linked to the overactive immune response, according to a recent study.
New Tech Vastly Improves CRISPR/Cas9 Accuracy
A new CRISPR/Cas9 technology developed by scientists at UMass Medical School is precise enough to surgically edit DNA at nearly any genomic location, while avoiding potentially harmful off-target changes typically seen in standard CRISPR gene editing techniques.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,800+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,000+ scientific videos